discusses the advances in molecular and cellular biology that have affected all fields of biology and have had a tremendous impact on the understanding of the biology of myeloma; reviews the dramatic clinical response to novel agents that has prompted a re-evaluation of important signaling pathways in myeloma; covers bone marrow microenvionments, molecular genetics, and other various genetic changes.
